Woori Bio Co., Ltd. logo

Woori Bio Co., Ltd. (082850)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
926. 00
-20
-2.1142%
91.58B Market Cap
- P/E Ratio
50% Div Yield
156,639 Volume
- Eps
946
Previous Close
Add Transaction
Day Range
919 964
Year Range
712 2,675
Want to track 082850 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

082850 closed today lower at ₩926, a decrease of -2.1142% from yesterday's close, completing a monthly decrease of -19.1266% or -₩219. Over the past 12 months, 082850 stock lost -54.4963%.
082850 pays dividends to its shareholders, with the most recent payment made on Jan 05, 2016.
Woori Bio Co., Ltd. has completed 1 stock splits, with the recent split occurring on May 04, 2009.
The company's stock is traded on one exchange.

082850 Chart

People also search for

Fine M-Tec Co., Ltd.
8,930
-2.5109%
Genexine Co., Ltd.
2,755
+1.2868%
TiumBio Co., Ltd.
4,950
-1.5905%
GeneOne Life Science Inc.
2,670
0%
Iljin Diamond Co. Ltd.
9,160
0%

Woori Bio Co., Ltd. (082850) FAQ

What is the stock price today?

The current price is ₩926.00.

On which exchange is it traded?

Woori Bio Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 082850.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 50%.

What is its market cap?

As of today, the market cap is 91.58B.

Has Woori Bio Co., Ltd. ever had a stock split?

Woori Bio Co., Ltd. had 1 splits and the recent split was on May 04, 2009.

Woori Bio Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
- Employees
- Last Dividend
4 May 2009 Last Split
- IPO Date

Overview

Woori Bio Co., Ltd. is distinguished in the biotechnology landscape, focusing on the development, manufacturing, and distribution of innovative healthcare products and services. The company’s mission is to enhance human health and well-being through its commitment to research and innovation in various biotechnological fields, encompassing pharmaceuticals, biochemistry, and regenerative medicine. Woori Bio stands at the forefront of medical technology progression, significantly impacting the pharmaceutical, healthcare, and possibly agricultural sectors by pioneering in the creation of biosimilar drugs and advanced medical solutions. This commitment places Woori Bio at the heart of the ever-evolving biotechnology industry, where its contributions to medical science are vital in inventing new treatments and therapies aimed at improving life quality across the globe.

Products and Services

The offerings of Woori Bio Co., Ltd. cover a broad spectrum in the biotechnology sector, including:

  • Pharmaceuticals: Woori Bio's pharmaceuticals division is dedicated to the research, development, and production of innovative drugs and biosimilar products. These efforts aim to make treatments more accessible and affordable, ultimately contributing to global health improvement by offering alternative solutions to costly biologics.
  • Biochemistry: The company explores the chemical processes within and related to living organisms. Through its biochemistry initiatives, Woori Bio develops biochemical compounds and diagnostics that play a critical role in disease detection and management, facilitating earlier diagnosis and tailored treatment strategies.
  • Regenerative Medicine: Woori Bio is also a key player in regenerative medicine, focusing on repairing, replacing, or regenerating human cells, tissues, or organs to restore or establish normal function. This area has the potential to revolutionize the medical field by offering new solutions for previously untreatable conditions, marking significant advancements in healthcare.

Contact Information

Address: -
Phone: -